Evidence map›Paper›PMID 36463538›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2023

Exploring the in vitro anticancer activities of Re(I) picolinic acid and its fluorinated complex derivatives on lung cancer cells: a structural study.

Mabu L Matlou, Frederick P Malan, Sanah Nkadimeng, Lyndy McGaw, Vuyelwa J Tembu, Amanda-Lee E Manicum

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review of Recent Medicinal Applications of Rhenium(I) Tricarbonyl Complexes.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mabu L MatlouDepartment of Chemistry, Tshwane University of Technology, P.O. Box X680, Pretoria, 0001, South Africa.
Frederick P MalanDepartment of Chemistry, University of Pretoria, 02 Lynnwood Road, Hatfield, Pretoria, 0001, South Africa.
Sanah NkadimengDepartment of Life and Consumer Sciences, University of South Africa, Private Bag X6, Florida Campus, Florida, 1710, South Africa.
Lyndy McGawPhytomedicine Programme, Department of Paraclinical Sciences, University of Pretoria, Private Bag X04, Onderstepoort, 0110, South Africa.
Vuyelwa J TembuDepartment of Chemistry, Tshwane University of Technology, P.O. Box X680, Pretoria, 0001, South Africa.
Amanda-Lee E ManicumDepartment of Chemistry, Tshwane University of Technology, P.O. Box X680, Pretoria, 0001, South Africa. ManicumAE@tut.ac.za.
Tshwane University of Technology · ZAUniversity of Pretoria · ZAUniversity of South Africa · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fifteen rhenium(I) tricarbonyl complexes of the form fac-[Re(N,O')(CO)

Indexed as

Lung NeoplasmsRheniumAnimalsCrystallography, X-RayHumansLigandsMagnetic Resonance SpectroscopyMammalsModels, MolecularMolecular StructurePicolinic AcidsLigandspicolinic acidPicolinic AcidsRheniumCrystallographyCytotoxicityImidazole-based ligandsN,O-LigandsPicolinic acid derivativesRhenium(I) tricarbonyl

Identifiers

PMID36463538
OpenAlexW4310668092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.